英菲格拉替尼(Infigratinib)2025年多少钱可以买到

Infigratinib is also known as Infigratinib, Truseltiq, Infigratinib, and Infigratinib. This article will introduce in detail the latest price information, storage methods, and medication precautions of this drug.

How much will Infigratinib cost in 2025?

As of July 2025, Infigratinib has not yet been launched in China, nor has it been included in Chinese medical insurance.

Specifications and Prices

The latest market data in 2025 shows that the specifications of generic drugs produced by Lucius in Laos are 100mg*21 capsules/box, and the price remains in the range of US$450-500. The price is for reference only. Please consult professionals for the actual price.

How to store

Infigratinib capsules should be stored at room temperature between 20°C and 25°C, avoiding direct sunlight and humid environments. You can bring medicines with you when you go out for a short period of time, but please note that the temperature does not exceed 30°C. The medicine bottle should be tightly capped as soon as possible after taking medicine to prevent moisture. Improper storage may cause the drug to become ineffective and affect the therapeutic effect.

Will Infigratinib cause side effects

Similar to other targeted drugs, Infigratinib may produce some adverse reactions during treatment. Most side effects are mild and can be controlled through appropriate treatment.

Common side effects

Some patients may experience symptoms such as nail changes, oral ulcers, dry eyes, fatigue, etc. These reactions usually do not affect continued medication and can be alleviated through symptomatic treatment. It is recommended that patients prepare artificial tears to relieve dry eyes and use soft-bristled toothbrushes to reduce oral irritation.

Serious adverse reactions

A small number of patients may develop retinopathy, hyperphosphatemia and other serious reactions. Regular eye examinations and blood phosphorus monitoring should be performed during treatment. When the serum phosphorus level exceeds 7.5mg/dL, the drug needs to be temporarily stopped and phosphorus-lowering measures need to be taken.

Drug interactions of Infigratinib

A variety of drugs may affect the efficacy of Infigratinib or increase the risk of adverse reactions. Patients should pay special attention to the following conditions.

Interactions with CYP3A modulators

Strong CYP3A inhibitors such as clarithromycin will increase the plasma concentration of infigratinib and increase the risk of side effects. CYP3A inducers such as carbamazepine will reduce drug concentration and affect the therapeutic effect. Dosage adjustments may be required when using these medications.

Interaction with gastric acid inhibitors

Proton pump inhibitors (such as omeprazole) will significantly reduce the absorption rate of infigratinib. If combined use is necessary, it is recommended to take it 12 hours apart. H2 receptor antagonists (such as ranitidine) should be taken at 2-hour intervals, and antacids should be taken at 2-hour intervals.

During treatment with infigratinib, patients may experience reactions such as fatigue and loss of appetite. It is recommended to maintain a regular schedule, exercise appropriately, and eat a balanced diet. If vision changes or severe discomfort occur, seek medical attention promptly. The doctor will adjust the medication plan according to the specific situation.